• IP addresses are NOT logged in this forum so there's no point asking. Please note that this forum is full of homophobes, racists, lunatics, schizophrenics & absolute nut jobs with a smattering of geniuses, Chinese chauvinists, Moderate Muslims and last but not least a couple of "know-it-alls" constantly sprouting their dubious wisdom. If you believe that content generated by unsavory characters might cause you offense PLEASE LEAVE NOW! Sammyboy Admin and Staff are not responsible for your hurt feelings should you choose to read any of the content here.

    The OTHER forum is HERE so please stop asking.

Siao liao. 837 cases liao. Going towards 1000

These 2 idiots are hiding in cck cemetery now. Scared of Kenna infected because if their inferior mRNA vaccines. Heng I booked sinopharm. Free things are never good.
Go on. Continue your delusion. The world needs idiots like you for a healthy balanced ecosystem .
 
Liar liar. Its only 82%. Shameless doctors lying? Jeez.
Lockdown please. Last time minister said 80% and we would have herd immunity and can normalize.
I want to expose his lies and incompetencies!

We've already normalized. Thanks to 80% of people in Singapore being vaccinated, we're back to normal already. Go look at how busy the malls are once again. Sinkies are also in force back in the parks, gyms and socializing. Just keep to 5 in a group and no alcohol after 1030pm, okay?
 
I think he is anesthetist. Just a guess.
Don't think anesthetist will get to see a patient who is a medium and brought in through a&e by his mom and speaks like a retard.

Only a suicidal mentally ill patient will be brought in a&e by his mom and speaks like a retard.
 
Don't think anesthetist will get to see a patient who is a medium and brought in through a&e by his mom and speaks like a retard.

Only a suicidal mentally ill patient will be brought in a&e by his mom and speaks like a retard.
anesthetist can be called to sedate the patient for the psychiatrist you know ....
 
Go on. Continue your delusion. The world needs idiots like you for a healthy balanced ecosystem .


buyer's remorse liao.


this professor says many need to prepare will for those taken gene based vaccines. take care.

 
Looks like the shit is hitting the fan.

Better go to the barber shop and get a haircut asap.

And I recommend this haircut:

 
U poke wrong vaccines liao. Now ur pap says wanna give non mRNA as boosters.
You are clearly as dumb as a doorbell. Your mom certainly raised a fool. :rolleyes:

1631697470293.png
 
These 2 idiots are hiding in cck cemetery now. Scared of Kenna infected because if their inferior mRNA vaccines. Heng I booked sinopharm. Free things are never good.
Not hiding and not afraid of anything. Fully vaccinated, happy with life and looking forward to a post-pandemic world. The ones who are running scared right now are the unvaxxed.

All vaccines protect. Congratulations on getting your sinopharm shot soon. :thumbsup:

As for hoping for people to die, please note that what you wish for always comes around. Karma is a bitch.
 
Not hiding and not afraid of anything. Fully vaccinated, happy with life and looking forward to a post-pandemic world. The ones who are running scared right now are the unvaxxed.

All vaccines protect. Congratulations on getting your sinopharm shot soon. :thumbsup:

As for hoping for people to die, please note that what you wish for always comes around. Karma is a bitch.


never wished for any sinkies to die. but those kept wanting to go for more mrna booster are just testing their luck. good luck to you. those pro vaxxer ppl are always hoping for unvaxxed people to die isn't it?
 
let's see your mrna works or not? going to hit 1 k tonight. likely all mrna are infected.
You really are dumb. Of course lah... 90% of Sinkees already vaccinated. So all the infected are vaccinated.... and thank god they are! :thumbsup:

And yes, vaccines do work.

COVID vaccine effects wane over time but still prevent death and severe illness

September 15, 2021 7.07pm

Several countries – including the UK – are now offering third COVID-19 shots amid reports of vaccines proving less effective over time. But do these countries really need to embark on widespread booster campaigns? Here’s what research tells us so far about how vaccines are performing.
One study suggests that after four months of the second dose, the Pfizer/BioNTech vaccine is less effective at preventing infection (classified as a positive PCR test), with protection falling from 96% to 84%. However, the research is a preprint, meaning that its results have yet to be formally reviewed by other scientists.
Similarly, real-life data from Israel suggests that over-60s who received their second dose of the Pfizer vaccine in March 2021 were 1.6 times better protected against infection than those who received their second dose two months earlier. However, the data was less clear cut when looking across other age groups. This study also hasn’t yet been peer reviewed.
Data for the Moderna vaccine shows that functional antibodies (those able to stop viruses from entering cells) persisted in most people for six months after vaccination. However, there was a gradual decrease in performance against the beta variant of the virus, and the study didn’t assess the vaccine against the now-dominant delta variant.

Get your news from people who know what they’re talking about.​

A separate preprint has looked at vaccine effectiveness against delta, and found both the Oxford/AstraZeneca and Pfizer vaccines were less effective at preventing infection when facing this variant. Similar findings have been reported by the US Centers for Disease Control and Prevention.
While all these studies may sound alarming, most are yet to be formally reviewed, so their results need to be treated with caution. They also measure different things. Some look at numbers of positive PCR tests rather than symptoms or disease. Others consider antibody levels or the response to different variants. Really, we need to consider what the most important goals of vaccination are when assessing performance.

Vaccines still protective​

An ideal vaccine would completely prevent infection and so stop people catching and spreading the virus. However, earlier on in the pandemic, reports appeared of people being reinfected with COVID-19 as well as of antibodies waning – and high levels of antibodies are thought to be important in preventing infection from starting. So it’s been suspected for a while that creating a vaccine that completely blocks infection wouldn’t be possible.
Indeed, antibodies are just one indicator of an effective immune response. We also need T lymphocytes that kill the virus, and immune memory to enable us to quickly produce lots of these killer T cells and antibody-producing B cells. Here the news is much more positive. Studies have shown that both killer T cells and immune memory persist well.
What this could mean is that some people might not have enough antibodies to completely prevent infection, but can still fight the infection off and stop it from taking hold. If this were the case, you would expect vaccines to reduce the impact or severity of disease. And this is where we are seeing good news.
A person being transferred from an ambulance into hospital
You are far more likely to be hospitalised with COVID-19 if you haven’t been doubled vaccinated. Andy Rain/EPA-EFE
Reports in the UK and the US are showing fewer vaccinated people requiring hospitalisation or developing severe symptoms from the delta variant. For example, fully vaccinated people in the US have been shown to be five times less likely to get COVID-19 and ten times less likely to be hospitalised or die from it.
Similarly, the Israeli study mentioned above showed that in people aged 40-59, four months after vaccination, vaccines were 98% effective at preventing people from being hospitalised with COVID-19. After six months, protection remained high, at 94%.
For people over the age of 60, though, the data shows a bigger drop off in performance, with protection against hospitalisation lower after four months (91%) and six months (86%). This difference may be due to older people being less able to mount a good immune response following vaccination, as well as the challenge of the delta variant.
However, what’s clear is that the vaccines are highly effective at protecting against severe disease compared with those who have not had a vaccine. And this, really, is the most important goal of vaccination – to stop people getting dangerously ill and dying.

Turning on the boosters​

Despite protection against severe disease remaining high many months after vaccination, a number of governments have chosen to launch vaccine booster programmes. Will the third doses being rolled out by the UK and other governments be sufficient to provide long-term and even more highly protective immunity in the most vulnerable? The truth is, we don’t yet know.
We should remember that vaccination is just one of the ways we protect ourselves from infection, and that maybe other measures, such as mask wearing and ventilation, will still be needed if we cannot achieve sufficient protection. Indeed, as well as boosters, the British government has also outlined plans for reintroducing home working and mask wearing over the winter should the virus threaten to get out of hand.
A health worker being vaccinated
While western countries debate third and even fourth doses, many people in low-income nations haven’t been able to access a first. Nic Bothma/EPA-EFE
The other question we have to ask ourselves is whether we should actually be looking to help other vulnerable people across the world. It’s been estimated that the richest countries have more than enough vaccines already, even if boosters are used and children are vaccinated.
The most important goal of vaccination is to protect against severe disease and death, yet many countries haven’t given even 2% of their population a first vaccine dose, enabling the virus to thrive at a huge cost to lives. Really, can we look the other way?
 
never wished for any sinkies to die. but those kept wanting to go for more mrna booster are just testing their luck. good luck to you. those pro vaxxer ppl are always hoping for unvaxxed people to die isn't it?
I have never wished for anyone to die. Not after I have personally seen a friend die of COVID. Please read my prior posts.
 
You really are dumb. Of course lah... 90% of Sinkees already vaccinated. So all the infected are vaccinated.... and thank god they are! :thumbsup:

And yes, vaccines do work.

COVID vaccine effects wane over time but still prevent death and severe illness

September 15, 2021 7.07pm

Several countries – including the UK – are now offering third COVID-19 shots amid reports of vaccines proving less effective over time. But do these countries really need to embark on widespread booster campaigns? Here’s what research tells us so far about how vaccines are performing.
One study suggests that after four months of the second dose, the Pfizer/BioNTech vaccine is less effective at preventing infection (classified as a positive PCR test), with protection falling from 96% to 84%. However, the research is a preprint, meaning that its results have yet to be formally reviewed by other scientists.
Similarly, real-life data from Israel suggests that over-60s who received their second dose of the Pfizer vaccine in March 2021 were 1.6 times better protected against infection than those who received their second dose two months earlier. However, the data was less clear cut when looking across other age groups. This study also hasn’t yet been peer reviewed.
Data for the Moderna vaccine shows that functional antibodies (those able to stop viruses from entering cells) persisted in most people for six months after vaccination. However, there was a gradual decrease in performance against the beta variant of the virus, and the study didn’t assess the vaccine against the now-dominant delta variant.

Get your news from people who know what they’re talking about.​

A separate preprint has looked at vaccine effectiveness against delta, and found both the Oxford/AstraZeneca and Pfizer vaccines were less effective at preventing infection when facing this variant. Similar findings have been reported by the US Centers for Disease Control and Prevention.
While all these studies may sound alarming, most are yet to be formally reviewed, so their results need to be treated with caution. They also measure different things. Some look at numbers of positive PCR tests rather than symptoms or disease. Others consider antibody levels or the response to different variants. Really, we need to consider what the most important goals of vaccination are when assessing performance.

Vaccines still protective​

An ideal vaccine would completely prevent infection and so stop people catching and spreading the virus. However, earlier on in the pandemic, reports appeared of people being reinfected with COVID-19 as well as of antibodies waning – and high levels of antibodies are thought to be important in preventing infection from starting. So it’s been suspected for a while that creating a vaccine that completely blocks infection wouldn’t be possible.
Indeed, antibodies are just one indicator of an effective immune response. We also need T lymphocytes that kill the virus, and immune memory to enable us to quickly produce lots of these killer T cells and antibody-producing B cells. Here the news is much more positive. Studies have shown that both killer T cells and immune memory persist well.
What this could mean is that some people might not have enough antibodies to completely prevent infection, but can still fight the infection off and stop it from taking hold. If this were the case, you would expect vaccines to reduce the impact or severity of disease. And this is where we are seeing good news.
A person being transferred from an ambulance into hospital
You are far more likely to be hospitalised with COVID-19 if you haven’t been doubled vaccinated. Andy Rain/EPA-EFE
Reports in the UK and the US are showing fewer vaccinated people requiring hospitalisation or developing severe symptoms from the delta variant. For example, fully vaccinated people in the US have been shown to be five times less likely to get COVID-19 and ten times less likely to be hospitalised or die from it.
Similarly, the Israeli study mentioned above showed that in people aged 40-59, four months after vaccination, vaccines were 98% effective at preventing people from being hospitalised with COVID-19. After six months, protection remained high, at 94%.
For people over the age of 60, though, the data shows a bigger drop off in performance, with protection against hospitalisation lower after four months (91%) and six months (86%). This difference may be due to older people being less able to mount a good immune response following vaccination, as well as the challenge of the delta variant.
However, what’s clear is that the vaccines are highly effective at protecting against severe disease compared with those who have not had a vaccine. And this, really, is the most important goal of vaccination – to stop people getting dangerously ill and dying.

Turning on the boosters​

Despite protection against severe disease remaining high many months after vaccination, a number of governments have chosen to launch vaccine booster programmes. Will the third doses being rolled out by the UK and other governments be sufficient to provide long-term and even more highly protective immunity in the most vulnerable? The truth is, we don’t yet know.
We should remember that vaccination is just one of the ways we protect ourselves from infection, and that maybe other measures, such as mask wearing and ventilation, will still be needed if we cannot achieve sufficient protection. Indeed, as well as boosters, the British government has also outlined plans for reintroducing home working and mask wearing over the winter should the virus threaten to get out of hand.
A health worker being vaccinated
While western countries debate third and even fourth doses, many people in low-income nations haven’t been able to access a first. Nic Bothma/EPA-EFE
The other question we have to ask ourselves is whether we should actually be looking to help other vulnerable people across the world. It’s been estimated that the richest countries have more than enough vaccines already, even if boosters are used and children are vaccinated.
The most important goal of vaccination is to protect against severe disease and death, yet many countries haven’t given even 2% of their population a first vaccine dose, enabling the virus to thrive at a huge cost to lives. Really, can we look the other way?


u should be wondering why 85k sinkies took sinovac in sinkapore non infected by covid? 85k is more than pfizer trail 3 participants but 1 also dun have? just think it through. no time to entertain you.
 
u should be wondering why 85k sinkies took sinovac in sinkapore non infected by covid? 85k is more than pfizer trail 3 participants but 1 also dun have? just think it through. no time to entertain you.
I don't need your entertaining. I have said this many times. All vaccines protect.

I don't know from whose arse you pulled out the data that people who took Sinovac are not infected. :roflmao:
 
You really are dumb. Of course lah... 90% of Sinkees already vaccinated. So all the infected are vaccinated.... and thank god they are! :thumbsup:

And yes, vaccines do work.

COVID vaccine effects wane over time but still prevent death and severe illness

September 15, 2021 7.07pm

Several countries – including the UK – are now offering third COVID-19 shots amid reports of vaccines proving less effective over time. But do these countries really need to embark on widespread booster campaigns? Here’s what research tells us so far about how vaccines are performing.
One study suggests that after four months of the second dose, the Pfizer/BioNTech vaccine is less effective at preventing infection (classified as a positive PCR test), with protection falling from 96% to 84%. However, the research is a preprint, meaning that its results have yet to be formally reviewed by other scientists.
Similarly, real-life data from Israel suggests that over-60s who received their second dose of the Pfizer vaccine in March 2021 were 1.6 times better protected against infection than those who received their second dose two months earlier. However, the data was less clear cut when looking across other age groups. This study also hasn’t yet been peer reviewed.
Data for the Moderna vaccine shows that functional antibodies (those able to stop viruses from entering cells) persisted in most people for six months after vaccination. However, there was a gradual decrease in performance against the beta variant of the virus, and the study didn’t assess the vaccine against the now-dominant delta variant.

Get your news from people who know what they’re talking about.​

A separate preprint has looked at vaccine effectiveness against delta, and found both the Oxford/AstraZeneca and Pfizer vaccines were less effective at preventing infection when facing this variant. Similar findings have been reported by the US Centers for Disease Control and Prevention.
While all these studies may sound alarming, most are yet to be formally reviewed, so their results need to be treated with caution. They also measure different things. Some look at numbers of positive PCR tests rather than symptoms or disease. Others consider antibody levels or the response to different variants. Really, we need to consider what the most important goals of vaccination are when assessing performance.

Vaccines still protective​

An ideal vaccine would completely prevent infection and so stop people catching and spreading the virus. However, earlier on in the pandemic, reports appeared of people being reinfected with COVID-19 as well as of antibodies waning – and high levels of antibodies are thought to be important in preventing infection from starting. So it’s been suspected for a while that creating a vaccine that completely blocks infection wouldn’t be possible.
Indeed, antibodies are just one indicator of an effective immune response. We also need T lymphocytes that kill the virus, and immune memory to enable us to quickly produce lots of these killer T cells and antibody-producing B cells. Here the news is much more positive. Studies have shown that both killer T cells and immune memory persist well.
What this could mean is that some people might not have enough antibodies to completely prevent infection, but can still fight the infection off and stop it from taking hold. If this were the case, you would expect vaccines to reduce the impact or severity of disease. And this is where we are seeing good news.
A person being transferred from an ambulance into hospital
You are far more likely to be hospitalised with COVID-19 if you haven’t been doubled vaccinated. Andy Rain/EPA-EFE
Reports in the UK and the US are showing fewer vaccinated people requiring hospitalisation or developing severe symptoms from the delta variant. For example, fully vaccinated people in the US have been shown to be five times less likely to get COVID-19 and ten times less likely to be hospitalised or die from it.
Similarly, the Israeli study mentioned above showed that in people aged 40-59, four months after vaccination, vaccines were 98% effective at preventing people from being hospitalised with COVID-19. After six months, protection remained high, at 94%.
For people over the age of 60, though, the data shows a bigger drop off in performance, with protection against hospitalisation lower after four months (91%) and six months (86%). This difference may be due to older people being less able to mount a good immune response following vaccination, as well as the challenge of the delta variant.
However, what’s clear is that the vaccines are highly effective at protecting against severe disease compared with those who have not had a vaccine. And this, really, is the most important goal of vaccination – to stop people getting dangerously ill and dying.

Turning on the boosters​

Despite protection against severe disease remaining high many months after vaccination, a number of governments have chosen to launch vaccine booster programmes. Will the third doses being rolled out by the UK and other governments be sufficient to provide long-term and even more highly protective immunity in the most vulnerable? The truth is, we don’t yet know.
We should remember that vaccination is just one of the ways we protect ourselves from infection, and that maybe other measures, such as mask wearing and ventilation, will still be needed if we cannot achieve sufficient protection. Indeed, as well as boosters, the British government has also outlined plans for reintroducing home working and mask wearing over the winter should the virus threaten to get out of hand.
A health worker being vaccinated
While western countries debate third and even fourth doses, many people in low-income nations haven’t been able to access a first. Nic Bothma/EPA-EFE
The other question we have to ask ourselves is whether we should actually be looking to help other vulnerable people across the world. It’s been estimated that the richest countries have more than enough vaccines already, even if boosters are used and children are vaccinated.
The most important goal of vaccination is to protect against severe disease and death, yet many countries haven’t given even 2% of their population a first vaccine dose, enabling the virus to thrive at a huge cost to lives. Really, can we look the other way?
These are ad hoc hypotheses authorities make after it was proven vaccines are not effective as they have claimed. When more deaths and serious illnesses are reported, don't you think they will come up with other excuses? :o-o:
 
I smell quite good. Ask the new NYP grad nurse assigned to my clinic. She likes to get pretty close.
Hooooo! I can smell your sour bouquet from all all across the internet bro. Sure you wash under your pits? :sick:
 
Back
Top